Medical Professional financing for your medical practice! Learn how to get funding with medical practice financing. More Info Here!
Call: 904-551-6090
Read The Interesting Snippets Below For Exciting Health-Care News!
Probiotic reduces risk of infections for preschoolers
– http://www.reuters.com/healthNews
NEW YORK (Reuters Health) – A trial in Mexico suggests probiotics may help protect kids from the mild, but seemingly constant, illnesses they pick up in daycare.
Continue Reading On http://www.reuters.com/healthNews »
U.S. FDA approves Celgene drug for psoriatic arthritis
– http://www.reuters.com
March 21 (Reuters) – U.S. health regulators on Friday approved a Celgene Corp drug to treat psoriatic arthritis, a type of arthritis associated with the skin disease psoriasis that causes joint pain, stiffness and swelling.
Continue Reading On http://www.reuters.com »
CAIRO/LONDON (Reuters) – Gilead Sciences, facing mounting criticism over the high price of its new hepatitis C pill Sovaldi, has offered to supply the medicine to Egypt at a 99 percent discount to the U.S. price.
Continue Reading On http://www.reuters.com/healthNews »
CONAKRY, March 21 (Reuters) – The death toll from an outbreak of a haemorrhagic fever in Guinea’s southeastern forest region has climbed to 29, while the number of cases has risen to 49, a health ministry official in the west African country said on Friday.
Continue Reading On http://www.reuters.com »
CONAKRY (Reuters) – The death toll from an outbreak of a haemorrhagic fever in Guinea’s southeastern forest region has climbed to 29, while the number of cases has risen to 49, a health ministry official in the west African country said on Friday.
Continue Reading On http://www.reuters.com/healthNews »
(Adds company comment, details of Egypt price deal, updates share prices)
Continue Reading On http://www.reuters.com »
No down payment medical, dental and healthcare provider practice financing here! + More News: Death toll from Guinea haemorrhagic fever rises to 29 + MORE 03/21/2014
No comments:
Post a Comment